Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

149 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter study.
Kim JH, Seo S, Kim JH, Koh SJ, Ahn Y, Jung KH, Ahn JH, Kim SB, Kim TW, Hong YS, Kim SY, Kim JE, Kim SW, Lee DH, Lee JC, Choi CM, Yoon S, Jeong JH, Kim HJ, Suh KJ, Kim SH, Kim YJ, Min YJ, Baek JH, Park SR. Kim JH, et al. Among authors: min yj. Cancer Med. 2022 Feb;11(3):705-714. doi: 10.1002/cam4.4476. Epub 2021 Dec 9. Cancer Med. 2022. PMID: 34889062 Free PMC article.
Prospective phase II trial of a combination of fixed dose rate infusion of gemcitabine with cisplatin and UFT as a first-line treatment in patients with advanced non-small-cell lung carcinoma.
Shin SJ, Kim H, Baek JH, Ahn JJ, Jegal Y, Seo KW, Park CR, Shin JK, Jung JP, Kim JW, Cha HJ, Kwon WJ, Jeong AK, Noh YJ, Park JH, Min YJ. Shin SJ, et al. Among authors: min yj. Lung Cancer. 2008 Apr;60(1):83-91. doi: 10.1016/j.lungcan.2007.09.013. Epub 2007 Nov 14. Lung Cancer. 2008. PMID: 18006180 Clinical Trial.
Prospective phase II trial of a combination of gemcitabine and UFT as first-line treatment in elderly patients with advanced non-small cell lung cancer.
Baek JH, Kim H, Ahn JJ, Jegal Y, Seo KW, Ra SW, Park CR, Jung JP, Kim JW, Lee YJ, Cha HJ, Kwon WJ, Noh YJ, Oh S, Park JH, Min YJ. Baek JH, et al. Among authors: min yj. Lung Cancer. 2012 Jun;76(3):368-72. doi: 10.1016/j.lungcan.2011.11.021. Epub 2011 Dec 20. Lung Cancer. 2012. PMID: 22192919 Clinical Trial.
Gefitinib versus pemetrexed as second-line treatment in patients with nonsmall cell lung cancer previously treated with platinum-based chemotherapy (KCSG-LU08-01): an open-label, phase 3 trial.
Sun JM, Lee KH, Kim SW, Lee DH, Min YJ, Yun HJ, Kim HK, Song HS, Kim YH, Kim BS, Hwang IG, Lee K, Jo SJ, Lee JW, Ahn JS, Park K, Ahn MJ; Korean Cancer Study Group. Sun JM, et al. Among authors: min yj. Cancer. 2012 Dec 15;118(24):6234-42. doi: 10.1002/cncr.27630. Epub 2012 Jun 6. Cancer. 2012. PMID: 22674612 Free article. Clinical Trial.
149 results